However, following lncSLCO1C1 downregulation, such an increased tumour growth was abolished upon oxaliplatin treatment (SGC7901‐DDP shRNA vs. SGC7901 shRNA, p > .05), suggesting lncSLCO1C1 mediate GC resistance to chemotherapy. Here, TIMM8A is linked to neoplasm.